Indian benchmark indices fell for the third consecutive session as Brent crude breached $111 per barrel, escalating domestic inflation concerns.

Swiss drugmaker Roche is seeking US FDA approval for its once-daily oral breast cancer therapy following clinical trial data showing a 30% reduction in disease recurrence.